Tag: Aker ASA

Aker ASA: Mandatory Notification of Trade

OSLO, Norway, Aug. 14, 2025 /PRNewswire/ -- Aker ASA today bought 9,056 own shares at an average price of NOK 688.2461 per share. The shares...

Aker ASA reports second quarter and half-year results 2025

OSLO, Norway, July 16, 2025 /PRNewswire/ -- The Net Asset Value ("NAV") of Aker ASA and holding companies ("Aker") was NOK 66.5 billion at...

Aker Horizons ASA: Half-year results 2025

FORNEBU, Norway, July 15, 2025 /PRNewswire/ -- Aker Horizons ASA (OSE: "AKH"), a developer of green energy and industry, today announced results for the...

Aker Horizons ASA: Half-year results 2025

FORNEBU, Norway, July 15, 2025 /PRNewswire/ -- Aker Horizons ASA (OSE: "AKH"), a developer of green energy and industry, today announced results for the...

Aker Horizons ASA: Half-year results 2025

FORNEBU, Norway, July 15, 2025 /PRNewswire/ -- Aker Horizons ASA (OSE: "AKH"), a developer of green energy and industry, today announced results for the...

Aker ASA: Presentation of Second-Quarter and Half-Year Results 2025

OSLO, Norway, July 3, 2025 /PRNewswire/ -- Aker ASA will publish its financial results for the second quarter and half-year of 2025 on July...

Aker ASA: Conditional Share Lending Agreement Relating to Merger with Aker Horizons

FORNEBU, Norway, June 11, 2025 /PRNewswire/ -- Reference is made to the merger between Aker Horizons ASA's ("Aker Horizons") subsidiary Aker Horizons Holding AS and...

Aker ASA: Mandatory Notification of Trade

OSLO, Norway, June 6, 2025 /PRNewswire/ -- Aker ASA today bought 4,400 own shares at an average price of NOK 617.4108 per share. The shares were...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Comments

This field is for validation purposes and should be left unchanged.

HomeTagsAker ASA

Zealand Pharma announces Boehringer Ingelheim’s survodutide Phase III trial in people living with obesity showed targeted 34% visceral and 63% liver fat reduction, while...

Head-to-head Study Validates the Clinical Advantage of New-generation Biased GLP-1: Ecnoglutide Delivers 35% Greater Weight Loss than Semaglutide

Head-to-head Study Validates the Clinical Advantage of New-generation Biased GLP-1: Ecnoglutide Delivers 35% Greater Weight Loss than Semaglutide

Tag: Aker ASA

Aker ASA: Mandatory Notification of Trade

Aker ASA reports second quarter and half-year results 2025

Aker Horizons ASA: Half-year results 2025

Aker Horizons ASA: Half-year results 2025

Aker Horizons ASA: Half-year results 2025

Aker ASA: Presentation of Second-Quarter and Half-Year Results 2025

Aker ASA: Conditional Share Lending Agreement Relating to Merger with Aker Horizons

Aker ASA: Mandatory Notification of Trade

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us